Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $38.88

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received an average rating of “Moderate Buy” from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $38.8750.

Several equities analysts have commented on the stock. BTIG Research decreased their price objective on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. TD Cowen lowered their price target on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a report on Monday, November 10th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Zacks Research downgraded Astrana Health from a “hold” rating to a “strong sell” rating in a research report on Tuesday, February 10th. Finally, Needham & Company LLC started coverage on Astrana Health in a research note on Friday, December 12th. They set a “buy” rating and a $28.00 target price on the stock.

Astrana Health Stock Down 2.8%

ASTH opened at $20.33 on Wednesday. Astrana Health has a 1-year low of $18.08 and a 1-year high of $34.80. The stock’s fifty day simple moving average is $23.51 and its 200 day simple moving average is $26.34. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. The stock has a market cap of $1.14 billion, a PE ratio of 107.01, a price-to-earnings-growth ratio of 0.62 and a beta of 0.90.

Institutional Investors Weigh In On Astrana Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Signaturefd LLC grew its stake in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after acquiring an additional 388 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the period. Strs Ohio acquired a new position in shares of Astrana Health during the 4th quarter worth approximately $40,000. Covestor Ltd increased its holdings in shares of Astrana Health by 210.6% during the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.